• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VMC
Click for more information
0.00% 6.1¢

VENUS METALS CORPORATION LIMITED - Corporate Spotlight

Market Cap $11.57M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

VMC holds a significant portfolio of gold projects and Joint Ventures in WA with a focus... VMC holds a significant portfolio of gold projects and Joint Ventures in WA with a focus on the Youanmi region with an indicated and inferred JORC gold resources of c. 1.2 Million Oz of Gold, with exciting exploration upside from the surrounding 340 km2 of tenements.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
6.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.57M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 70599 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 97302 2
View Market Depth
Last trade - 16.12pm 01/10/2024 (20 minute delay) ?
VMC (ASX) Chart

Top Stories

Iress runs 'hot' for Wealth Within's stock tips

Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.